Exceptionally Large and Innovative Pipeline The breast cancer pipeline is the largest in the pharmaceutical industry with 815 products in active development across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially […]
July 2014 Life Science Industry Research Reports
PharmaPoint: Acute Coronary Syndrome – US Drug Forecast and Market Analysis to 2023
GlobalData estimates that the total market size for the 7MM in 2013 was $12.3bn, comprised of $5.0bn in branded drug sales (40%) and $7.3bn in generic sales (60%). GlobalData expects that the ACS drug market will grow at a CAGR […]
Non-Small Cell Lung Cancer Market to 2020 – New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market
GBI Research, a leading business intelligence provider, has released its latest research report, “Non-Small Cell Lung Cancer Market to 2020 – New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market”. The value of the Non-Small […]
U.S. Neuromodulation, Neurovascular, Neurosurgical and Monitoring Device Market
This market, collectively referred to as the U.S. neurological device market, continues to present attractive growth opportunities and is projected to grow.The market for neurological devices in the U.S. includes cerebrospinal fluid (CSF) shunts, CSF external drainage systems, intracranial pressure […]
Cangrelor (Acute Coronary Syndrome) – Forecast and Market Analysis to 2023
GlobalData has released its new PharmaPoint Drug Evaluation report, “Cangrelor (Acute Coronary Syndrome) – Forecast and Market Analysis to 2023”. The current ACS market – primarily comprised of antithrombotics, antihypertensives, and statins – is flush with well-established standard-of-care therapies, many […]
PharmaPoint: Acute Coronary Syndrome – Japan Drug Forecast and Market Analysis to 2023
GlobalData estimates that the total market size for the 7MM in 2013 was $12.3bn, comprised of $5.0bn in branded drug sales (40%) and $7.3bn in generic sales (60%). GlobalData expects that the ACS drug market will grow at a CAGR […]
Pharmaceutical Packaging Products to 2018
US demand to reach $22.1 billion in 2018 Demand for pharmaceutical packaging products in the US will rise 4.9 percent annually to $22.1 billion in 2018. Growth will accelerate slightly from the pace of the 2008-2013 period as drug makers […]
ADHD Therapeutics to 2020 – Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations
GBI Research has released the pharma report, “ADHD Therapeutics to 2020 Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations” Changes in diagnostic criteria have reduced the symptom threshold for diagnosis and finally bring the […]
Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders
Overview Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders has a focus in biomarkers for neurodegenerative diseases and diagnostic applications in development. Biomarkers have been a heavily studied topic of interest, and recently on the rise is […]
PharmaPoint: Acute Coronary Syndrome – Global Drug Forecast and Market Analysis to 2023
GlobalData estimates that the total market size for the 7MM in 2013 was $12.3bn, comprised of $5.0bn in branded drug sales (40%) and $7.3bn in generic sales (60%). GlobalData expects that the ACS drug market will grow at a CAGR […]
Stay In Touch